Biosearch Technologies, Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in innovative solutions for molecular biology and genomics. Founded in 1996, the company has established itself as a trusted provider of high-quality products and services, catering to research institutions and commercial laboratories worldwide. With a focus on custom oligonucleotides, probes, and reagents, Biosearch Technologies stands out for its commitment to precision and reliability. Their unique offerings, including advanced qPCR assays and innovative fluorescent dyes, have garnered recognition for enhancing research efficiency and accuracy. Over the years, Biosearch Technologies has achieved significant milestones, solidifying its market position as a go-to source for cutting-edge biotechnological tools. The company continues to drive advancements in the field, supporting scientific discovery and innovation across various sectors.
How does Biosearch Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biosearch Technologies, Inc.'s score of 60 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biosearch Technologies, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of LGC Limited, which may influence its climate-related strategies and commitments. Despite the lack of direct emissions data, Biosearch Technologies, Inc. is part of a broader corporate family that may have established climate initiatives. However, there are no documented reduction targets or climate pledges available for the company at this time. This suggests that while the company may be engaged in sustainability efforts, specific commitments or achievements in carbon reduction are not publicly disclosed. As a subsidiary, Biosearch Technologies, Inc. may align its practices with those of LGC Limited, which could include adherence to industry standards and potential future commitments to reduce carbon emissions. However, without specific data or targets, the company's current climate impact remains unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 6,734,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 6,555,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biosearch Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

